Cross Country Healthcare (NASDAQ:CCRN) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Cross Country Healthcare (NASDAQ:CCRN) announced its quarterly earnings results on Wednesday. The business services provider reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.02, Briefing.com reports. The company had revenue of $379.17 million for the quarter, compared to the consensus estimate of $374.38 million. Cross Country Healthcare had a net margin of 3.60% and a return on equity of 16.93%. Cross Country Healthcare’s revenue for the quarter was down 39.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.84 EPS. Cross Country Healthcare updated its Q2 guidance to $0.10-0.20 EPS and its Q2 2024 guidance to 0.100-0.200 EPS.

Cross Country Healthcare Stock Performance

Cross Country Healthcare stock traded down $1.16 during mid-day trading on Thursday, hitting $16.74. The company’s stock had a trading volume of 1,107,072 shares, compared to its average volume of 451,103. Cross Country Healthcare has a one year low of $15.65 and a one year high of $28.75. The stock has a market cap of $580.54 million, a PE ratio of 8.64, a P/E/G ratio of 1.91 and a beta of 0.77. The company has a 50 day moving average of $17.94 and a 200-day moving average of $20.10.

Insider Activity

In related news, insider Karen Mote sold 6,216 shares of Cross Country Healthcare stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $16.95, for a total transaction of $105,361.20. Following the completion of the sale, the insider now owns 35,101 shares in the company, valued at approximately $594,961.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 4.90% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on CCRN shares. Barrington Research cut their price target on Cross Country Healthcare from $26.00 to $24.00 and set an “outperform” rating for the company in a report on Tuesday, February 27th. Benchmark reduced their price target on shares of Cross Country Healthcare from $21.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday. TheStreet lowered shares of Cross Country Healthcare from a “b-” rating to a “c+” rating in a research report on Friday, March 1st. Finally, Truist Financial reduced their target price on shares of Cross Country Healthcare from $22.00 to $16.00 and set a “hold” rating on the stock in a report on Thursday, February 22nd. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $21.33.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.